Pharmaceuticals - LG/Merck in deal to make off-patent drugs

被引：0
作者：
不详
机构：
来源：
EUROPEAN CHEMICAL NEWS | 1997年 / 68卷 / 1780期
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [41] Generic versions launched as Viagra ((R)) goes off-patent
    Sklan, Alexandra
    [J]. PHARMACEUTICAL PATENT ANALYST, 2013, 2 (05) : 582 - 582
  • [42] Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
    Alpern, Jonathan D.
    Shahriar, Arman A.
    Xi, Min
    Thapa, Sunita
    Kodet, Amy J.
    Stauffer, William M.
    Benitez, Gabriela Vazquez
    Pawloski, Pamala A.
    Dehmer, Steven P.
    [J]. JAMA NETWORK OPEN, 2020, 3 (08) : E2013595
  • [43] Dynamics of price competition in Italian pharmaceutical off-patent market
    Perna, Serena
    Cangini, Agnese
    Marini, Roberto
    Guerrizio, Maria Alessandra
    Da Cas, Roberto
    Traversa, Giuseppe
    Trotta, Francesco
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [44] MARKET UPTAKE MODELS OF BIOSIMILARS AND OFF-PATENT BIOLOGICAL MEDICINES
    Moorkens, E.
    Meuwissen, N.
    Huys, I
    Vulto, A.
    Declerck, P.
    Simoens, S.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A452 - A452
  • [45] Policy options for sustainable access to off-patent antibiotics in Europe
    Dimitra Panteli
    Michael Anderson
    Thomas Fieldman
    Enrico Baraldi
    Thomas Tängdén
    Sabine Vogler
    Christine Årdal
    Elias Mossialos
    [J]. npj Antimicrobials and Resistance, 2 (1):
  • [46] APPLICATION OF MULTI-CRITERIA DECISION ANALYSIS (MCDA) SCORING AS AN HTA METHODOLOGY FOR OFF-PATENT PHARMACEUTICALS (OPP) IN EMERGING MARKETS
    Brixner, D.
    Maniadakis, N.
    Kalo, Z.
    Hu, S.
    Johnston, A.
    Shen, J.
    Wijaya, K. E.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A815 - A815
  • [47] Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study
    Gupta, Ravi
    Bollyky, Thomas J.
    Cohen, Matthew
    Ross, Joseph S.
    Kesselheim, Aaron S.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 360
  • [48] Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
    Vandenplas, Yannick
    Simoens, Steven
    Van Wilder, Philippe
    Vulto, Arnold G.
    Huys, Isabelle
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] PHARMACEUTICALS Merck deal with South Korea's Hanwha bolsters move into biosimilars
    Jarvis, Lisa
    [J]. CHEMICAL & ENGINEERING NEWS, 2011, 89 (25) : 13 - 13
  • [50] The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia
    Tesar, Tomas
    Golias, Peter
    Masarykova, Lucia
    Kawalec, Pawel
    Inotai, Andras
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
12345